We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Sea Limited
SE
$69.5B
| $6.51M | 0.03% |
23,718
-93,753
| -80% | -$23.8M |
|
|
NVRO
477
DELISTED
NEVRO CORP.
NVRO
| $6.51M | 0.03% |
39,244
-87,537
| -69% | -$13.7M |
|
478
Rollins
ROL
$18.2B
| $6.45M | 0.03% |
188,513
+173,016
| +1,116% | +$6.04M |
|
479
State Street
STT
$50.7B
| $6.42M | 0.03% |
77,987
-41,476
| -35% | -$3.5M |
|
|
KLRS
480
Kalaris Therapeutics
KLRS
$96.8M
| $6.41M | 0.03% |
14,116
-146
| -1% | -$75.4K |
|
481
Yext
YEXT
$574M
| $6.4M | 0.03% |
+447,774
| New | +$6.23M |
|
482
Nutanix
NTNX
$16.9B
| $6.34M | 0.03% |
165,924
-86,863
| -34% | -$2.71M |
|
|
FSRD
483
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
| $6.34M | 0.03% |
+650,000
| New | +$6.4M |
|
484
Edison International
EIX
$26.4B
| $6.31M | 0.03% |
109,117
+95,885
| +725% | +$5.58M |
|
485
Vornado Realty Trust
VNO
$7.38B
| $6.3M | 0.03% |
134,925
-242,795
| -64% | -$11.4M |
|
486
Safe Bulkers
SB
$774M
| $6.29M | 0.03% |
+1,568,233
| New | +$5.49M |
|
487
Hilton Grand Vacations
HGV
$3.55B
| $6.23M | 0.03% |
+150,454
| New | +$6.53M |
|
488
The RealReal
REAL
$1.5B
| $6.2M | 0.03% |
313,996
+288,687
| +1,141% | +$5.9M |
|
489
HUB Group
HUBG
$2.92B
| $6.19M | 0.03% |
+187,566
| New | +$6.39M |
|
|
GSEV
490
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
| $6.19M | 0.03% |
+625,000
| New | +$6.19M |
|
491
Garrett Motion
GTX
$5.57B
| $6.19M | 0.03% |
+775,351
| New | +$5.7M |
|
492
StepStone Group
STEP
$3.82B
| $6.18M | 0.03% |
179,729
-39,387
| -18% | -$1.31M |
|
|
LEGO
493
DELISTED
Legato Merger Corp. Common stock
LEGO
| $6.17M | 0.03% |
615,868
| – | – |
|
|
LEGOW
494
CALL
DELISTED
Legato Merger Corp. Warrant
LEGOW
| $6.17M | 0.03% |
615,868
| – | – |
|
|
WLL
495
DELISTED
Whiting Petroleum Corporation
WLL
| $6.16M | 0.03% |
112,842
+50,527
| +81% | +$2.17M |
|
|
MTLS
496
Materialise
MTLS
$396M
| $6.14M | 0.03% |
254,850
+167,140
| +191% | +$4.68M |
|
497
Cohu
COHU
$2.5B
| $6.13M | 0.03% |
166,625
-307,920
| -65% | -$12.2M |
|
498
Bumble
BMBL
$373M
| $6.12M | 0.03% |
106,236
+63,476
| +148% | +$3.35M |
|
499
Eversource Energy
ES
$27.2B
| $6.05M | 0.03% |
+75,411
| New | +$6.35M |
|
|
WCN
500
Waste Connections
WCN
$42B
| $6.05M | 0.03% |
+50,668
| New | +$6.03M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.